Effects of Collagen, Ionophore A23187 and Prostaglandin E1 on the Phosphorylation of Specific Proteins in Blood Platelets

Overview

Journal Biochem J

Specialty Biochemistry

Date 1979 Feb 15

PMID 375934

Citations 22

Authors

R J Haslam

J A Lynham

J E Fox

Affiliations

Soon will be listed here.

Abstract

Human platelets that had been preincubated with 5-hydroxy[(3)H]tryptamine and [(32)P]P(i) were stirred with various agents; the secretion of 5-hydroxy[(3)H]tryptamine from platelet granules and the radioactivity of platelet [(32)P]phosphopolypeptides separated by sodium dodecyl sulphate/polyacrylamide-gel electrophoresis were then measured. Exposure of the platelets to collagen fibres or ionophore A23187 selectively increased the phosphorylation of polypeptides with apparent mol.wts. of 47000 (P47) and 20000 (P20) by approx. 3-fold, in association with the release of 5-hydroxy[(3)H]tryptamine. The 47000-mol.wt. phosphopolypeptide (P47) was clearly separated from platelet actin by the electrophoresis system used. Prostaglandin E(1), which inhibits platelet function by increasing platelet cyclic AMP, decreased the phosphorylation of polypeptides caused by collagen as well as the release of 5-hydroxy[(3)H]tryptamine. Prostaglandin E(1) also selectively increased the phosphorylation of distinct polypeptides with apparent mol.wts. of 24000 (P24) and 22000 (P22) by approx. 2-fold. As the phosphorylation reactions caused by collagen are probably mediated by an increase in Ca(2+) concentration in the platelet cytosol and may have a role in the release reaction [Haslam & Lynham (1977) Biochem. Biophys. Res. Commun.77, 714-722; (1978) Thromb. Res.12, 619-628], we suggest that a cyclic AMP-dependent phosphorylation of the 24000- and/or 22000-mol.wt. polypeptides caused by prostaglandin E(1) may initiate processes that decrease the Ca(2+) concentration in the cytosol, so inhibiting both the Ca(2+)-dependent phosphorylation reactions and the release reaction. Treatment of platelets with prostaglandin E(1) did not inhibit the increased phosphorylation of polypeptides with apparent mol.wts. of 47000 and 20000 (P47 and P20) caused by ionophore A23187, which may therefore short-circuit cyclic AMP-dependent mechanisms that decrease the Ca(2+) concentration in the platelet cytosol. As prostaglandin E(1) did inhibit the release of 5-hydroxy[(3)H]tryptamine by ionophore A23187, cyclic AMP may also inhibit the release reaction by additional mechanisms.

Citing Articles

Loss of pleckstrin defines a novel pathway for PKC-mediated exocytosis.

Lian L, Wang Y, Flick M, Choi J, Scott E, Degen J Blood. 2009; 113(15):3577-84.

PMID: 19190246 PMC: 2668855. DOI: 10.1182/blood-2008-09-178913.

PI3K regulates pleckstrin-2 in T-cell cytoskeletal reorganization.

Bach T, Kerr W, Wang Y, Bauman E, Kine P, Whiteman E Blood. 2006; 109(3):1147-55.

PMID: 17008542 PMC: 1785144. DOI: 10.1182/blood-2006-02-001339.

Phosphorylated pleckstrin induces cell spreading via an integrin-dependent pathway.

Roll R, Bauman E, Bennett J, Abrams C J Cell Biol. 2000; 150(6):1461-6.

PMID: 10995449 PMC: 2150702. DOI: 10.1083/jcb.150.6.1461.

Pleckstrin associates with plasma membranes and induces the formation of membrane projections: requirements for phosphorylation and the NH2-terminal PH domain.

Ma A, Brass L, Abrams C J Cell Biol. 1997; 136(5):1071-9.

PMID: 9060471 PMC: 2132483. DOI: 10.1083/jcb.136.5.1071.

Chemical cross-linking of pleckstrin in human platelets: evidence for oligomerization of the protein and its dissociation by protein kinase C.

McDermott A, Haslam R Biochem J. 1996; 317 ( Pt 1):119-24.

PMID: 8694752 PMC: 1217451. DOI: 10.1042/bj3170119.

References

Haslam R, Davidson M, Desjardins J . Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Biochem J. 1978; 176(1):83-95. PMC: 1186207. DOI: 10.1042/bj1760083. View

Apitz-Castro R, Ramirez E, Maingon R, De Murciano A, Ribbi A . Plasma membrane phosphorylation by endogenous phosphate donors in human blood platelets. Selectivity of the action of dibutyryl cyclic AMP. Biochim Biophys Acta. 1976; 455(2):371-82. DOI: 10.1016/0005-2736(76)90312-6. View

Haslam R, Lynham J . Relationship between phosphorylation of blood platelet proteins and secretion of platelet granule constituents II. Effects of different inhibitors. Thromb Res. 1978; 12(4):619-28. DOI: 10.1016/0049-3848(78)90251-7. View

Haslam R, Davidson M, Davies T, Lynham J, McClenaghan M . Regulation of blood platelet function by cyclic nucleotides. Adv Cyclic Nucleotide Res. 1978; 9:533-52. View

KASER-GLANZMANN R, Jakabova M, George J, LUSCHER E . Stimulation of calcium uptake in platelet membrane vesicles by adenosine 3',5'-cyclic monophosphate and protein kinase. Biochim Biophys Acta. 1977; 466(3):429-40. DOI: 10.1016/0005-2736(77)90336-4. View

Haslam R, Lynham J . Increased phosphorylation of specific blood platelet proteins in association with the release reaction. Biochem Soc Trans. 1976; 4(4):694-7. DOI: 10.1042/bst0040694. View

Feinstein M, Becker E, Fraser C . Thrombin, collagen and A23187 stimulated endogenous platelet arachidonate metabolism: differential inhibition by PGE1, local anesthetics and a serine-protease inhibitor. Prostaglandins. 1977; 14(6):1075-93. DOI: 10.1016/0090-6980(77)90286-6. View

Haslam R, Lynham J . Relationship between phosphorylation of blood platelet proteins and secretion of platelet granule constituents. I. Effects of different aggregating agents. Biochem Biophys Res Commun. 1977; 77(2):714-22. DOI: 10.1016/s0006-291x(77)80037-5. View

Daniel J, Holmsen H, Adelstein R . Thrombin-stimulated myosin phosphorylation in intact platelets and its possible involvement secretion. Thromb Haemost. 1977; 38(4):984-9. View

10.

Charo I, Feinman R, DETWILER T . Inhibition of platelet secretion by an antagonist of intracellular calcium. Biochem Biophys Res Commun. 1976; 72(4):1462-7. DOI: 10.1016/s0006-291x(76)80178-7. View

11.

Tada M, Kirchberger M, Repke D, Katz A . The stimulation of calcium transport in cardiac sarcoplasmic reticulum by adenosine 3':5'-monophosphate-dependent protein kinase. J Biol Chem. 1974; 249(19):6174-80. View

12.

Kaulen H, Gross R . Purification and properties of a soluble cyclic AMP-dependent protein kinase from human platelets. Hoppe Seylers Z Physiol Chem. 1974; 355(4):471-80. DOI: 10.1515/bchm2.1974.355.1.471. View

13.

Salzman E . Cyclic AMP and platelet function. N Engl J Med. 1972; 286(7):358-63. DOI: 10.1056/NEJM197202172860708. View

14.

Mustard J, Perry D, Ardlie N, Packham M . Preparation of suspensions of washed platelets from humans. Br J Haematol. 1972; 22(2):193-204. DOI: 10.1111/j.1365-2141.1972.tb08800.x. View

15.

Haslam R . Roles of cyclic nucleotides in platelet function. Ciba Found Symp. 1975; 35:121-51. DOI: 10.1002/9780470720172.ch7. View

16.

Chaiken R, Pagano D, DETWILER T . Regulation of platelet phosphorylase. Biochim Biophys Acta. 1975; 403(2):315-25. DOI: 10.1016/0005-2744(75)90061-3. View

17.

Gear A, Schneider W . Control of platelet glycogenolysis; Activation of phosphorylase kinase by calcium. Biochim Biophys Acta. 1975; 392(1):111-20. DOI: 10.1016/0304-4165(75)90171-3. View

18.

Rubin C, Rosen O . Protein phosphorylation. Annu Rev Biochem. 1975; 44:831-87. DOI: 10.1146/annurev.bi.44.070175.004151. View

19.

Steiner M . Endogenous phosphorylation of platelet membrane proteins. Arch Biochem Biophys. 1975; 171(1):245-54. DOI: 10.1016/0003-9861(75)90029-6. View

20.

Tada M, Kirchberger M, Katz A . Phosphorylation of a 22,000-dalton component of the cardiac sarcoplasmic reticulum by adenosine 3':5'-monophosphate-dependent protein kinase. J Biol Chem. 1975; 250(7):2640-7. View